Mycobacterium Citations List: May 2025

Literature Citations

1. Structural and Biological Investigation of (E)-2-((2-butyl-4-chloro-1H-imidazol-5-yl)methylene) hydrazine-1-carbothioamide: Synthesis, Structural insights, Antitubercular Screening, Molecular Docking, DFT, and ADME Studies. Adole, V.A., A.R. Kumar, S. Selvaraj, R.A. Shinde, G.B. Yelmame, S.K. Ghotekar, and A.P. Frit. Journal of Molecular Structure, 2025. 1341: 142560. ISI[001492666500003].
[WOS]. TB_05_2025.

2. Plant-based Multi-target Directed Antitubercular Ligand Identification from Ipomea sepiaria with Application of Bioinformatics Methodology. Asra, F., F.M. Husain, V. Kannan, S. Chintala, and N. Dumala. South African Journal of Botany, 2025. 181: p. 405-414. ISI[001480891500001].
[WOS]. TB_05_2025.

3. Coumarin Hybrids: Dual-target Candidates for Future Antimicrobial and Antitubercular Therapies. Bavishi, A., H. Vala, S. Thakrar, S. Swami, D. Sarkar, R. Shukla, J. Kamdar, and A. Shah. Future Medicinal Chemistry, 2025. 17(10): p. 1131-1142. PMID[40353302].
[PubMed]. TB_05_2025.

4. Early Preclinical Development of Mycobacterium tuberculosis Amino Acid Biosynthesis Pathway Inhibitor DRILS-1398 as a Potential Anti-Tb Drug. Biswas, D., R.K. Edwin, K.S. Kumar, A. Alam, D. Kumar, S. Chakraborty, G. Bulusu, F.J. Ahmad, G.G. Shenoy, L. Singh, M. Agarwal, F. Siraj, S. Oruganti, P. Misra, N.Z. Ehtesham, M. Pal, and S.E. Hasnain. iScience, 2025. 28(6): 112537. ISI[001492895800002].
[WOS]. TB_05_2025.

5. Unprecedented In Vivo Activity of Telacebec against Mycobacterium leprae. Chauffour, A., E. Cambau, K. Pethe, N. Veziris, and A. Aubry. PLOS Neglected Tropical Diseases, 2025. 19(5): e0013076. PMID[40338896]. PMCID[PMC12061105].
[PubMed]. TB_05_2025.

6. Evaluation of the Cytotoxicity and Antibacterial Activity of a Synthetic Tunicamycin Derivative against Mycobacterium avium Complex. Colombatti Olivieri, M.A., N.P.J. Price, M.A. Jackson, and J.P. Bannantine. Frontiers in Microbiology, 2025. 16: 1604400. PMID[40443998]. PMCID[PMC12119611].
[PubMed]. TB_05_2025.

7. Next-generation Rifamycins for the Treatment of Mycobacterial Infections. Dartois, V., T. Lan, U.S. Ganapathy, C.F. Wong, J.P. Sarathy, D.C. Jimenez, I.M. Alshiraihi, H. Lam, S. Rodriguez, M. Xie, M. Soto-Ojeda, M. Jackson, W. Wheat, N.C. Dillman, K. Kostenkova, J. Schmitt, L. Mann, A. Richter, P. Imming, J. Sarathy, F. Kaya, S. Paruchuri, B. Tatek, C. Folvar, J. Proietto, M. Zimmerman, M. Gonzalez-Juarrero, C.C. Aldrich, and T. Dick. Proceedings of the National Academy of Sciences of the United States of America, 2025. 122(18): e2423842122. PMID[40310456]. PMCID[PMC12067261].
[PubMed]. TB_05_2025.

8. Nifuroxazide and 4-Hydroxybenzhydrazone Derivatives as New Antiparasitic (Trypanosoma cruzi and Leishmania mexicana) and Anti-Mycobacterium tuberculosis Agents. Delgado-Maldonado, T., D.V. Navarrete-Carriola, L.K. Vázquez-Jiménez, A.D. Paz-González, B. Wan, S. Franzblau, O.M. Mohammed, L. Rodríguez-Páez, C. Aguirre-Alvarado, V. Alcántara-Farfán, J. Cordero-Martínez, D. Bandyopadhyay, A. Moreno-Rodríguez, and G. Rivera. Pharmaceutics, 2025. 17(5). PMID[40430911]. PMCID[PMC12114619].
[PubMed]. TB_05_2025.

9. Design, Synthesis, Biological Evaluation, and Computational Insights of 2-(Aryl)benzo[D]imidazo[2,1-b]thiazole-7-sulfonamide Derivatives as Potent Antitubercular and Antibacterial Agents. Deshmukh, H.S., V.A. Adole, S.N. Mali, and B.S. Jagdale. BMC Chemistry, 2025. 19(1): p. 126. PMID[40361163]. PMCID[PMC12076927].
[PubMed]. TB_05_2025.

10. Click Chemistry Assisted Synthesis of Imidazo [1,2-a]pyrimidine-1,2,3-triazole Hybrids as Promising Antitubercular Agents: Design, Characterization, In-vitro Biological Evaluation, Molecular Docking, DFT and In-silico ADME Studies. Dinesha, P., S. Naik, N.S. Veeranagaiah, and D. Udayakumar. Journal of Molecular Structure, 2025. 1340: 142535. ISI[001491030900003].
[WOS]. TB_05_2025.

11. The Effects of Cyclic Peptide [R4W4] in Combination with First-line Therapy on the Survival of Mycobacterium avium. Kelley, M., K. Sasaninia, A. Badaoui, I. Glassman, A. Abnousian, N. Rai, R.K. Tiwari, and V. Venketaraman. Frontiers in Cellular and Infection Microbiology, 2025. 15: 1547376. PMID[40308965]. PMCID[PMC12041069].
[PubMed]. TB_05_2025.

12. Computational Design, Synthesis, and Biological Assessment of Some Pyrrolo 3,4-C Pyrroles Targeting Mycobacterium tuberculosis. Lavanya, M., R. Sundararaj, K.S. Mani, K. Balu, M. Durai, P. Alam, P. Sd, M. Durai, and Y.H. Ahn. ChemistrySelect, 2025. 10(17): e202405796. ISI[001480078900001].
[WOS]. TB_05_2025.

13. Discovery of Novel Pyrimidinetrione Derivatives as DPRE1 Inhibitors with Potent Antimycobacterial Activities. Liang, J., Y. Liu, Q. Guan, Y. Li, M.Z. Zheng, X.L. Zhang, L.X. Chen, and H. Li. European Journal of Medicinal Chemistry, 2025. 289: 117416. PMID[39999693].
[PubMed]. TB_05_2025.

14. Structural Isomerisation Affects the Antitubercular Activity of Adamantyl-isoxyl Adducts. Lu, Y.C., D. Partleton, F.M. Gugu, A.Y.G. Alhejaili, S. Norris, J.J. Harburn, J.H. Gill, J.D. Sellars, and A.K. Brown. Journal of Enzyme Inhibition and Medicinal Chemistry, 2025. 40(1): 2502600. ISI[001492413300001].
[WOS]. TB_05_2025.

15. Synthesis, Characterization, Biological Evaluation and In Silico Studies of Quinoline-1,2,3-triazole-anilines as Potential Antitubercular and Anti-HIV Agents. Magwaza, S.S., D. Naidu, O.E. Oyeneyin, S. Senzani, N.P. Mkhwanazi, and M. Tukulula. Molecules, 2025. 30(10). PMID[40430292]. PMCID[PMC12114169].
[PubMed]. TB_05_2025.

16. Strategic Synthesis and Antimycobacterial Evaluation of Coumarin- and Quinoline-substituted S-triazine Derivatives Via Palladium-catalyzed Suzuki Coupling. Mahyavanshi, J.B., J.V. Pandya, and M.R. Solanki. Russian Journal of Organic Chemistry, 2025. 61(3): p. 456-461. ISI[001483786200003].
[WOS]. TB_05_2025.

17. Development of Carprofen Analogues with Activity against Mycobacterium tuberculosis. Martin, L.T., C. Daniel, M. Guldberg-Allen, A. Navaratnarajah, S. Anselmi, T.D. Burova, S. Willcocks, H.C. Hailes, and S. Bhakta. Bioorganic & Medicinal Chemistry, 2025. 127: p. 118226. PMID[40367912].
[PubMed]. TB_05_2025.

18. Combined Dual Β-Lactams and Diazabicyclooctane Β-Lactamase Inhibitor Is Highly Effective against Mycobacterium abscessus Species In Vitro. Misawa, K., T. Nishimura, M. Yoshikawa, R. Shimamura, S. Kashimura, Y. Enoki, K. Taguchi, K. Matsumoto, and N. Hasegawa. Journal of Global Antimicrobial Resistance, 2025. 42: p. 142-150. PMID[40015478].
[PubMed]. TB_05_2025.

19. Characterization of a Novel Virulent Mycobacteriophage Kashi-SSH1 (KSSH 1) Depicting Genus-specific Broad-spectrum Anti-Mycobacterial Activity. Nayak, T., A. Kakkar, L.K. Jaiswal, G. Kandwal, A.K. Singh, L. Temple, and A. Gupta. Life Sciences, 2025. 369: 123546. PMID[40058575].
[PubMed]. TB_05_2025.

20. Ethnobotanical Survey and Antimycobacterial Activities of Plants Used against Tuberculosis in Lubumbashi, Dr Congo. Numbi Wa Ilunga, E., M. Mbayo Kitambala, K. Muya, O. Lachenaud, J. Mukekwa Maloba, J.B. Lumbu Simbi, and V. Fontaine. Tropical Medicine and Health, 2025. 53(1): p. 64. PMID[40319331]. PMCID[PMC12049048].
[PubMed]. TB_05_2025.

21. Synthesis, Evaluation of Biological Activity, and Structure-activity Relationships of New Amidrazone Derivatives Containing Cyclohex-1-ene-1-carboxylic acid. Paprocka, R., J. Kutkowska, E. Paczkowska, G.M. Mwaura, A. Eljaszewicz, and A. Helmin-Basa. Molecules, 2025. 30(8). PMID[40333909]. PMCID[PMC12029444].
[PubMed]. TB_05_2025.

22. 5-(3,5-dinitrophenyl)-1,3,4-oxadiazol-2-amine Derivatives, their Precursors, and Analogues: Synthesis and Evaluation of Novel Highly Potent Antitubercular Agent. Pflégr, V., J. Stolaříková, G. Karabanovich, J. Maixnerová, A. Pál, J. Korduláková, Z. Šanderová, M. Liegertová, J. Roh, F. Trejtnar, J. Vinšová, and M. Krátký. PLOS One, 2025. 20(5): e0324608. PMID[40440331]. PMCID[PMC12121777].
[PubMed]. TB_05_2025.

23. New Triazolopyrimidines with Improved Activity against Mycobacterium tuberculosis. Pogula, S.R., A. Deshpande, E. Greve, S. Chowdhury, and T. Parish. ACS Medicinal Chemistry Letters, 2025. ISI[001480208100001].
[PubMed]. TB_05_2025.

24. Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents. Poyraz Yılmaz, P., N. Kulabaş, A. Bozdeveci, S.K. Vagolu, M. Imran, E. Tatar, Ş. Alpay Karaoğlu, D. Sriram, A.A.R. Mahmood, and İ. Küçükgüzel. Chemical Biology & Drug Design, 2025. 105(5): e70126. PMID[40415348]. PMCID[PMC12104612].
[PubMed]. TB_05_2025.

25. In Vitro Activity of Imipenem/Relebactam Alone and in Combination against Cystic Fibrosis Isolates of Mycobacterium abscessus. Sanders, M., S.W. Kim, A. Shinde, D. Fletcher-Williams, E. Quach, and P. Beringer. Antibiotics, 2025. 14(5). PMID[40426552]. PMCID[PMC12108374].
[PubMed]. TB_05_2025.

26. Exploring Ferrocenyl Derivatives of Sulfa-drugs as Potential Antimalarial and Anti-Mycobacterium tuberculosis Agents. Setlaba, K., V. Mavumengwana, L. Baatjies, M.T. Ndlovu, C.H. Kaschula, and P. Chellan. Inorganica Chimica Acta, 2025. 584: 122725. ISI[001480895200001].
[WOS]. TB_05_2025.

27. Synthesis of Thiophene-based Flavone and Pyrazole Derivatives through Intramolecular Cyclization and Condensation Reactions: Molecular Docking, Biological Evaluation Including Antimicrobial, Antioxidant, and Antitubercular Activities. Shah, R.S., P.K. Verma, H.K. Sharma, and S. Kumar. Indian Journal of Heterocyclic Chemistry, 2025. 35(1): p. 91. ISI[001476632000011].
[WOS]. TB_05_2025.

28. Coumarin-triazole-thiazole Hybrids: A New Avenue in Antitubercular Agents. Shaikh, S.A., S.R. Labhade, S.S. Chobe, M.V. Gaikwad, R.A. More, B.U. Patil, and D.R. Boraste. Bioorganic Chemistry, 2025. 161: 108567. PMID[40378733].
[PubMed]. TB_05_2025.

29. Efficacy and Immunogenicity of rKVAC85B in a BCG Prime-boost Regimen against H37RV and Hn878 Mycobacterium Tuberculosis Strains. Shin, E., J.S. Yun, Y.R. Lee, H.R. Cha, S.M. Kim, S.J. Shin, S.W. Lee, G.T. Chung, D. Kim, J.S. Yoo, J.S. Kim, and H.S. Jeong. PLOS One, 2025. 20(5): e0322147. PMID[40367100]. PMCID[PMC12077692].
[PubMed]. TB_05_2025.

30. A Cationic Main-chain Poly(carbonate-imidazolium) Potent against Mycobacterium abscessus and Other Resistant Bacteria in Mice. Si, Z., Y. Sun, C. Tan, Y.J. Ooi, M. Li, C. Raju, J. Shubi, Y.H. Gan, Y. Zhu, P. Li, M.B. Chan-Park, and K. Pethe. Biomaterials, 2025. 316: 123003. PMID[39709850].
[PubMed]. TB_05_2025.

31. Exploration of 3-substituted benzofuran-tethered sulfamoyl triazoles as Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation. Singampalli, A., R. Bandela, B. Bakchi, S. Giovannuzzi, K. Biernacki, P.K. Agnivesh, S. Nanduri, N.P. Kalia, C.T. Supuran, and V.M. Yaddanapudi. ChemMedChem, 2025. ISI[001491184300001].
[WOS]. TB_05_2025.

32. Synthesis, Characterization, and Biological Evaluation of New Oxadiazole Analogues: A Comprehensive Experimental and Computational Investigation. Singh, N.K. and S. Ganguly. Chemistryselect, 2025. 10(17): e202500769. ISI[001480431400001].
[WOS]. TB_05_2025.

33. Sphingosine Kills Mycobacteria and Suppresses Mycobacterial Lung Infections. Wu, Y., F. Schnitker, Y. Liu, S. Keitsch, F. Caicci, F. Schumacher, A. Riehle, B. Pollmeier, J. Kehrmann, B. Kleuser, M. Kamler, I. Szabo, H. Grassmé, and E. Gulbins. Journal of Molecular Medicine, 2025. 103(5): p. 547-558. PMID[40153002]. PMCID[PMC12078450].
[PubMed]. TB_05_2025.

Patent Citations

34. A Novel Compound Acting against a Select Group of Bacteria. Lewis, K. and Y. Imai. Patent. 2025. WO2024-US539072025096791: 113 pp.
[Patent]. TB_05_2025.

35. Preparation of Aryl Fluorosulfate-Based Compounds as Inhibitors as Novel Antitubercular Agents. Yang, B., C.W. McNamara, A.K. Chatterjee, H.M. Petrassi, K.B. Sharpless, B. Qin, P. Sukheja, M. Love, A. Woods, and D. Liu. Patent. 2025. WO2024-US535002025096495: 144 pp.
[Patent]. TB_05_2025.